April 22, 2024

Lab Automation Community Meetup: BioLabs Heidelberg

Lab Automation Community Meetup: BioLabs Heidelberg
Go back

Laboratory automation is evolving rapidly, but many of the challenges we face are remarkably similar. Whether it’s robotics, digital workflows, data integration or connected laboratories, the best ideas often emerge when people share their experiences. That´s why the Rhine-Neckar Lab Automation Community was founded in 2026 as a joint initiative by 5-HT, BASF, bioRN Life Science Cluster and BioLabs Heidelberg. 

The network brings together researchers, technology providers and industry experts to exchange ideas, discuss challenges and learn from each other in an open and informal setting.

Next Community Meetup:

Thursday, 10 September 2026
16:30 – 20:00
BioLabs Heidelberg

short impulses:

  • Jochen Meier (Südzucker AG):Beyond Paper: Building the Connected Laboratory
    • Michael Fedler (Thermo Fisher Scientific):From Standalone Instruments to Connected Labs: An Introduction to Lab Integration
    • presentation by Eppendorf.

18:00 – 20:00
Dinner, networking and optional guided lab tour

 

How to join the Rhine-Neckar Lab Automation Community

If you would like to become part of the community, simply request to join the LinkedIn Community. Each application is reviewed to ensure a valuable exchange between researchers, technology providers and industry professionals.

Once your membership has been approved, you will receive access to the registration links for our meetups and future community activities.

register now

Our latest News

discover more
Celonic AG and Leukocare AG Announce Development Collaboration to Support Joint Clients with Complex Biologics and Advanced Drug Product Profiles

Celonic AG and Leukocare AG Announce Development Collaboration to Support Joint Clients with Complex Biologics and Advanced Drug Product Profiles

Basel, Switzerland / Martinsried, Germany – 28 July, 2026 Celonic AG, a Swiss-based biologics Contract Development and Manufacturing Organization (CDMO), and Leukocare AG, a leading provider of drug product development services, today announced a collaboration to support biopharmaceutical companies developing increasingly complex biologics. The collaboration brings together Celonic’s expertise in cell line development, drug substance […]

read more
Cardiac Arrhythmias: New Defibrillator System Expands Treatment Options at UKHD

Cardiac Arrhythmias: New Defibrillator System Expands Treatment Options at UKHD

At Heidelberg University Hospital (UKHD), there is a new treatment option for certain patients with severe cardiac arrhythmias: an implantable defibrillator in which the electrode—unlike in conventional defibrillators—is placed outside the heart and blood vessels. This protects the blood vessels. In addition, the system can correct some arrhythmias using mild electrical impulses before an electric […]

read more
The Individual Genetic Background Shapes the Evolution of Cancer

The Individual Genetic Background Shapes the Evolution of Cancer

Why do cancers develop differently in different people—even when they are exposed to the same risk factors? An international research group, including the German Cancer Research Center (DKFZ), has now demonstrated in mice that an organism’s genetic makeup significantly influences the course of cancer development. The findings, now published in Nature, provide new insights into […]

read more

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp